
Paul V. Ward
Examiner (ID: 4583)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1622, 1623 |
| Total Applications | 2519 |
| Issued Applications | 1801 |
| Pending Applications | 239 |
| Abandoned Applications | 539 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16893159
[patent_doc_number] => 11034692
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Naphthyridines as inhibitors of HPK1
[patent_app_type] => utility
[patent_app_number] => 16/542129
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 146582
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 597
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16542129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/542129 | Naphthyridines as inhibitors of HPK1 | Aug 14, 2019 | Issued |
Array
(
[id] => 16862752
[patent_doc_number] => 11021482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Pyrrolopyrimidine ITK inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/538354
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64745
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538354 | Pyrrolopyrimidine ITK inhibitors | Aug 11, 2019 | Issued |
Array
(
[id] => 15496121
[patent_doc_number] => 20200048249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => PTPN11 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/536923
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536923
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536923 | PTPN11 inhibitors | Aug 8, 2019 | Issued |
Array
(
[id] => 15209627
[patent_doc_number] => 20190367500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => QUINAZOLINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/535489
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16535489
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/535489 | Quinazoline derivative | Aug 7, 2019 | Issued |
Array
(
[id] => 16590505
[patent_doc_number] => 10899755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Benzothiazole compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/534039
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31174
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3928
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534039 | Benzothiazole compounds and uses thereof | Aug 6, 2019 | Issued |
Array
(
[id] => 19240584
[patent_doc_number] => 12010995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Oxadiazoline compounds or salts thereof, agrohorticultural fungicides containing the compounds, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/252455
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15136
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 845
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252455 | Oxadiazoline compounds or salts thereof, agrohorticultural fungicides containing the compounds, and methods of using the same | Aug 5, 2019 | Issued |
Array
(
[id] => 18127925
[patent_doc_number] => 11554120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
[patent_app_type] => utility
[patent_app_number] => 16/527802
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 33223
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16527802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/527802 | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor | Jul 30, 2019 | Issued |
Array
(
[id] => 15850455
[patent_doc_number] => 10640493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/526620
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46969
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526620 | Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer | Jul 29, 2019 | Issued |
Array
(
[id] => 15524677
[patent_doc_number] => 20200054644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => THERAPEUTIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/522550
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522550 | Therapeutic compounds and uses thereof | Jul 24, 2019 | Issued |
Array
(
[id] => 15147661
[patent_doc_number] => 20190352308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/522124
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522124 | KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS | Jul 24, 2019 | Abandoned |
Array
(
[id] => 17111718
[patent_doc_number] => 20210292315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => SELENIUM-CONTAINING ISOXAZOLAMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/261955
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261955 | SELENIUM-CONTAINING ISOXAZOLAMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | Jul 21, 2019 | Abandoned |
Array
(
[id] => 15990315
[patent_doc_number] => 20200171028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METALLOENZYME INHIBITOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/518279
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518279
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/518279 | METALLOENZYME INHIBITOR COMPOUNDS | Jul 21, 2019 | Abandoned |
Array
(
[id] => 17526792
[patent_doc_number] => 11299463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Process for the manufacture of pyrazoles or pyrimidones
[patent_app_type] => utility
[patent_app_number] => 16/517542
[patent_app_country] => US
[patent_app_date] => 2019-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13910
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517542
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517542 | Process for the manufacture of pyrazoles or pyrimidones | Jul 19, 2019 | Issued |
Array
(
[id] => 16925188
[patent_doc_number] => 11046649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
[patent_app_type] => utility
[patent_app_number] => 16/514382
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26740
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514382 | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase | Jul 16, 2019 | Issued |
Array
(
[id] => 16862741
[patent_doc_number] => 11021470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/514675
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 37899
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 397
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514675 | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof | Jul 16, 2019 | Issued |
Array
(
[id] => 17067224
[patent_doc_number] => 20210269439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PYRIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/257172
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257172 | Pyridopyrimidine derivative, preparation method therefor and medical use thereof | Jul 1, 2019 | Issued |
Array
(
[id] => 16549715
[patent_doc_number] => 10882864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Process for preparing BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/460889
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34491
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460889 | Process for preparing BTK inhibitors | Jul 1, 2019 | Issued |
Array
(
[id] => 20256089
[patent_doc_number] => 12428432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Thienopyrimidine derivatives having stereo configurations and use thereof in medicine
[patent_app_type] => utility
[patent_app_number] => 17/624572
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10716
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624572 | Thienopyrimidine derivatives having stereo configurations and use thereof in medicine | Jul 1, 2019 | Issued |
Array
(
[id] => 15323931
[patent_doc_number] => 20200002295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/458530
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16458530
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/458530 | Aminopyrazine derivatives as PI3K-g inhibitors | Jun 30, 2019 | Issued |
Array
(
[id] => 17065767
[patent_doc_number] => 20210267982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => FOLATE PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 17/256456
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256456 | Folate preparations | Jun 30, 2019 | Issued |